Inventor · disambiguated record
Chu-Biao Xue
Also filed as: XUE CHU-BIAO
59 granted patents·7 pending applications·1,062 citations·filing 1994–2022
99Inventor score
Files withINCYTE CORP36BRISTOL MYERS SQUIBB PHARMA CO9XUE CHU-BIAO6BRISTOL MYERS SQUIBB CO4DU PONT MERCK PHARMA4
Top patents by PatentIndex Score
66 records- 0199US11285140B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2020·Granted Mar 29, 2022·14 cites·2 claims
- 0298US9999619B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·38 cites·2 claims
- 0398US9464088B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2014·Granted Oct 11, 2016·57 cites·49 claims
- 0497US10695337B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2018·Granted Jun 30, 2020·21 cites·14 claims
- 0597US8765734B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsHUANG TAISHENG·Filed 2011·Granted Jul 1, 2014·116 cites·12 claims
- 0696US9550765B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Jan 24, 2017·19 cites·56 claims
- 0796US9200004B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Dec 1, 2015·25 cites·24 claims
- 0894US10265307B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2017·Granted Apr 23, 2019·10 cites·20 claims
- 0994US9849120B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Dec 26, 2017·12 cites·26 claims
- 1094US9676750B2Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 13, 2017·18 cites·53 claims
- 1194US6858626B2Cyclic hydroxamic acid as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 22, 2005·66 cites·20 claims
- 1293US9278950B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Mar 8, 2016·24 cites·55 claims
- 1392US10828290B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2019·Granted Nov 10, 2020·3 cites·29 claims
- 1492US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 1591US10517858B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as PIM kinase inhibitorsINCYTE CORP·Filed 2019·Granted Dec 31, 2019·6 cites·19 claims
- 1691US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 1791US7307086B23-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2005·Granted Dec 11, 2007·21 cites·24 claims
- 1891US6429213B1Cyclic hydroxamic acids as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 6, 2002·95 cites·42 claims
- 1990US7511050B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2007·Granted Mar 31, 2009·14 cites·110 claims
- 2090US6906053B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jun 14, 2005·33 cites·24 claims
- 2190US6890915B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted May 10, 2005·32 cites·24 claims
- 2287US7985730B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2009·Granted Jul 26, 2011·6 cites·5 claims
- 2387US7462624B2Purinone derivatives as HM74a agonistsINCYTE CORP·Filed 2007·Granted Dec 9, 2008·8 cites·81 claims
- 2486US6376665B1Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseDU PONT PHARM CO·Filed 2000·Granted Apr 23, 2002·23 cites·23 claims
- 2586US6268379B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsDU PONT PHARM CO·Filed 1999·Granted Jul 31, 2001·71 cites·28 claims
- 2686US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 2785US5563158AAromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1994·Granted Oct 8, 1996·26 cites·22 claims
- 2884US7700624B23-aminocyclopentanecrboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2006·Granted Apr 20, 2010·6 cites·38 claims
- 2984US7678798B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2005·Granted Mar 16, 2010·5 cites·35 claims
- 3082US7618970B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2005·Granted Nov 17, 2009·5 cites·29 claims
- 3182US7449467B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsPFIZER·Filed 2005·Granted Nov 11, 2008·5 cites·31 claims
- 3282US6984648B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 10, 2006·15 cites·21 claims
- 3382US6743807B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 1, 2004·15 cites·42 claims
- 3481US7482372B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jan 27, 2009·4 cites·6 claims
- 3581US6689771B2Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 10, 2004·14 cites·30 claims
- 3681US5703092AHydroxamic acid compounds as metalloprotease and TNF inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Dec 30, 1997·58 cites·11 claims
- 3780US7902205B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Mar 8, 2011·3 cites·36 claims
- 3879US8268826B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2009·Granted Sep 18, 2012·3 cites·17 claims
- 3979US7576089B23-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2004·Granted Aug 18, 2009·8 cites·2 claims
- 4077US2023043959A1Piperidin-4-yl azetidine derivatives as jak1 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 4176US11229631B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2020·Granted Jan 25, 2022·0 cites·4 claims
- 4276US8362003B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2011·Granted Jan 29, 2013·2 cites·8 claims
- 4374US8039478B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Oct 18, 2011·1 cites·22 claims
- 4474US7863285B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Jan 4, 2011·1 cites·27 claims
- 4574US7834021B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2003·Granted Nov 16, 2010·4 cites·4 claims
- 4672US6825215B21,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 30, 2004·5 cites·15 claims
- 4771US6642255B21,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alphaBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 4, 2003·5 cites·30 claims
- 4871US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 4971US5691329ACompounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Nov 25, 1997·13 cites·10 claims
- 5070US8703783B2Purinone derivatives as HM74A agonistsZHENG CHANGSHENG·Filed 2011·Granted Apr 22, 2014·2 cites·7 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →